发明公开
EP1897881A3 Compounds useful for the treatment of obesity, type II diabetes and CNS disorders
审中-公开
用于治疗肥胖症，II型糖尿病和CNS障碍的合适化合物
- 专利标题： Compounds useful for the treatment of obesity, type II diabetes and CNS disorders
- 专利标题（中）： 用于治疗肥胖症，II型糖尿病和CNS障碍的合适化合物
-
申请号： EP07122274.9申请日： 2003-06-19
-
公开(公告)号： EP1897881A3公开(公告)日： 2009-03-18
- 发明人: Johansson, Gary , Jenmalm Jensen, Annika , Beierlein, Katarina
- 申请人： Biovitrum AB (publ)
- 申请人地址： 112 76 Stockholm SE
- 专利权人： Biovitrum AB (publ)
- 当前专利权人： Biovitrum AB (publ)
- 当前专利权人地址： 112 76 Stockholm SE
- 优先权： SE0201925 20020620; SE0202181 20020711; US406120P 20020826; SE0202908 20021001; US434010P 20021217; SE0300357 20030210; US464701P 20030423
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; C07D495/04 ; A61P3/00 ; A61K31/4365
摘要：
The present invention relates to compounds of the general formula (I),
wherein P is sulfone or sulfonamide; and
A, B, W, X, Y and R 3 are as defined in the description;
to pharmaceutical compositions comprising these compounds, and to the use of the compounds for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes, and/or CNS disorders, to achieve reduction of body weight and of body weight gain.
wherein P is sulfone or sulfonamide; and
A, B, W, X, Y and R 3 are as defined in the description;
to pharmaceutical compositions comprising these compounds, and to the use of the compounds for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes, and/or CNS disorders, to achieve reduction of body weight and of body weight gain.
公开/授权文献
信息查询
